ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA)

CUSIP: 488445206

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
58,397,755
Total 13F shares
33,925,967
Share change
+4,897,671
Total reported value
$282,929,757
Put/Call ratio
8.5%
Price per share
$8.34
Number of holders
108
Value change
+$43,767,647
Number of buys
60
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13D/G 13F
Company
7.6%
4,080,420
$29,501,437 $0 31 Dec 2024
Woodline Partners LP
13F
Company
6.9%
4,048,653
$28,097,652 30 Sep 2024
13F
Nantahala Capital Management, LLC
13F 13D/G
Company
4.4%
from 13D/G
2,924,021
$20,292,705 30 Sep 2024
VANGUARD GROUP INC
13F
Company
4.7%
2,756,061
$19,127,063 30 Sep 2024
13F
FMR LLC
13F
Company
4%
2,313,202
$16,053,622 30 Sep 2024
13F
Samuel J. Braun
3/4/5
10%+ Owner
class O/S missing
3,153,000
$15,636,043 13 May 2021
Altium Capital Management LLC
13F
Company
2.9%
1,700,000
$11,798,000 30 Sep 2024
13F
683 Capital Management, LLC
13F
Company
2.1%
1,225,000
$8,501,500 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,043,864
$7,246,181 30 Sep 2024
13F
J. Goldman & Co LP
13F
Company
1.7%
984,182
$6,830,223 30 Sep 2024
13F
STATE STREET CORP
13F
Company
1.3%
772,825
$5,363,406 30 Sep 2024
13F
Stonepine Capital Management, LLC
13F
Company
1.2%
700,000
$4,858,000 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.1%
649,000
$4,504,060 30 Sep 2024
13F
Vestal Point Capital, LP
13F
Company
0.9%
525,000
$3,643,500 30 Sep 2024
13F
Retirement Planning Co of New England, Inc.
13F
Company
0.86%
499,505
$3,466,565 30 Sep 2024
13F
Stratos Wealth Partners, LTD.
13F
Company
0.72%
418,640
$2,905,362 30 Sep 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.66%
386,245
$2,681,000 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.61%
354,720
$2,461,757 30 Sep 2024
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.6%
350,000
$2,429,000 30 Sep 2024
13F
Mystic Asset Management, Inc.
13F
Company
0.53%
307,447
$2,133,682 30 Sep 2024
13F
Janney Montgomery Scott LLC
13F
Company
0.52%
305,069
$2,117,000 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.39%
227,164
$1,576,518 30 Sep 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.37%
214,798
$1,490,698 30 Sep 2024
13F
Velan Capital Investment Management LP
13F
Company
0.34%
200,000
$1,388,000 30 Sep 2024
13F
Propel Bio Management, LLC
13F
Company
0.31%
179,874
$1,248,326 30 Sep 2024
13F
Brandywine Global Investment Management, LLC
13F
Company
0.3%
177,900
$1,234,626 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.26%
152,907
$1,061,175 30 Sep 2024
13F
Monashee Investment Management LLC
13F
Company
0.26%
150,000
$1,041,000 30 Sep 2024
13F
Kovack Advisors, Inc.
13F
Company
0.25%
148,802
$1,032,686 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.25%
145,852
$1,012,214 30 Sep 2024
13F
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.01%
6,940
$1,000,000 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.22%
127,483
$884,732 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.22%
125,835
$873,295 30 Sep 2024
13F
Travis C. Mickle
3/4/5
President & CEO, Director
class O/S missing
171,774
$851,845 25 May 2022
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.21%
121,356
$842,211 30 Sep 2024
13F
Simplify Asset Management Inc.
13F
Company
0.21%
120,000
$832,800 30 Sep 2024
13F
CREDIT AGRICOLE S A
13F
Individual
0.18%
106,000
$735,640 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.17%
97,886
$679,329 30 Sep 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
95,143
$660,292 30 Sep 2024
13F
Arete Wealth Advisors, LLC
13F
Company
0.13%
77,972
$545,000 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.12%
67,909
$471,288 30 Sep 2024
13F
Caption Management, LLC
13F
Company
0.11%
62,000
$430,280 30 Sep 2024
13F
BARCLAYS PLC
13F
Company
0.1%
57,599
$399,737 30 Sep 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
57,480
$398,903 30 Sep 2024
13F
Sven Guenther
3/4/5
Chief Scientific Officer
class O/S missing
79,000
$391,769 31 Jan 2024
Christal M. M. Mickle
3/4/5
Chief Development Officer
class O/S missing
77,000
$381,851 31 Jan 2024
MARSHALL WACE, LLP
13F
Company
0.09%
52,077
$361,415 30 Sep 2024
13F
LMR Partners LLP
13F
Company
0.09%
50,000
$347,000 30 Sep 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.07%
40,600
$281,764 30 Sep 2024
13F
Sanctuary Advisors, LLC
13F
Company
0.05%
27,924
$267,652 30 Sep 2024
13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) as of Q4 2024

As of 31 Dec 2024, ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,925,967 shares. The largest 10 holders included Woodline Partners LP, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, FMR LLC, Altium Capital Management LLC, 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 108 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
105
Q4 2024 holders
108
Holder diff
3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .